InvestorsHub Logo
Followers 0
Posts 2218
Boards Moderated 0
Alias Born 05/12/2005

Re: A deleted message

Wednesday, 05/28/2014 12:03:02 AM

Wednesday, May 28, 2014 12:03:02 AM

Post# of 130502
That sticky is not only outdated, but it was wrong from the moment it was posted. My most blatant lie is:

However, all of the research regarding MANF treating chemically induced PD is obsolete now that we know how PD is caused. That includes all of the research reviewed by Jason. We've known about alpha syn for 10 years but for some reason the main focus of research has NOT gone through alpha syn. That has wasted a lot of money on GDNF and Neurturin.


This claim directly contradicts what was then and is still currently posted on the MJFF web site.

Parkinson's Disease Discovered

Parkinson's disease was first characterized extensively by an English doctor, James Parkinson, in 1817. Today, we understand Parkinson's disease to be a disorder of the central nervous system that results from the loss of cells in various parts of the brain, including a region called the substantia nigra. The substantia nigra cells produce dopamine, a chemical messenger responsible for transmitting signals within the brain that allow for coordination of movement. Loss of dopamine causes neurons to fire without normal control, leaving patients less able to direct or control their movement. Parkinson's disease is one of several diseases categorized by clinicians as movement disorders.

The exact cause of Parkinson's disease is unknown, although research points to a combination of genetic and environmental factors. If a continuum existed, with exclusively genetic causes at one end and exclusively environmental causes at the other, different Parkinson’s patients would likely fall at many different places along that continuum.

https://www.michaeljfox.org/understanding-parkinsons/living-with-pd/topic.php?causes

It's clear someone believes they have a better understanding of LymPro demand than the researchers and physicians Gerald and his advisors are in communication with, suggesting the corporate advisors are misguided in their efforts to bring the LymPro test to market. Time will tell, but the demand we see for LymPro once it is available will prove who is right and who is wrong in their beliefs.

It's also clear someone believes they have a better understanding of PD than the MJFF researchers themselves. Someone with this level of understanding should probably be involved in the MJFF research efforts, no?